Drug intelligence / Profile preview

Neurexan

Development stage
Phase 2
Lead developer
Heel
Modality
Small Molecules
Administration
Oral, Sublingual
01

Overview

Neurexan is a multi-component homeopathic medicinal product developed by Biologische Heilmittel Heel GmbH, primarily indicated for the treatment of nervous restlessness, stress-related symptoms, and sleep disturbances such as short-term insomnia. The formulation consists of four active ingredients: *Passiflora incarnata* (passionflower), *Avena sativa* (oats), *Coffea arabica* (coffee), and *Zincum isovalerianicum* (zinc valerate). Neurexan is designed to modulate the stress response by stabilizing the hypothalamic-pituitary-adrenal (HPA) axis and reducing stress-induced cortisol levels. Unlike conventional hypnotics, it aims to improve sleep efficiency and daytime performance without causing sedation, dependency, or morning grogginess. Clinical research, including Phase 2 trials, has utilized polysomnography (PSG) and electroencephalography (EEG) to evaluate its efficacy in addressing insomnia and stress-induced physiological changes.

Brand names
Neurexan
02

Targets

DRD (Dopamine receptors)ADRA2A (α2A)BZD site (GABA-A receptor benzodiazepine site)

Beyond the preview

Go deeper on Neurexan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurexan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call